876 related articles for article (PubMed ID: 25609452)
1. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis.
Chen HN; Wang Z; Li X; Zhou ZG
Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
Liu KS; Wong IO; Leung WK
World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer prevention from the point of Helicobacter.
Balaban YH; Simşek H; Tatar G
Turk J Gastroenterol; 2014 Aug; 25(4):463-7. PubMed ID: 25254545
[No Abstract] [Full Text] [Related]
4. The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions.
Piazuelo MB; Bravo LE; Mera RM; Camargo MC; Bravo JC; Delgado AG; Washington MK; Rosero A; Garcia LS; Realpe JL; Cifuentes SP; Morgan DR; Peek RM; Correa P; Wilson KT
Gastroenterology; 2021 Mar; 160(4):1106-1117.e3. PubMed ID: 33220252
[TBL] [Abstract][Full Text] [Related]
5. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
Liu D; He Q; Liu C
J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
[TBL] [Abstract][Full Text] [Related]
6. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis and potential reversibility of intestinal metaplasia - a milestone in gastric carcinogenesis.
Drnovsek J; Homan M; Zidar N; Smid LM
Radiol Oncol; 2024 Jun; 58(2):186-195. PubMed ID: 38643513
[TBL] [Abstract][Full Text] [Related]
8. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran.
Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z
Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of gastric cancer development after
Sugimoto M; Murata M; Yamaoka Y
World J Gastroenterol; 2020 Apr; 26(15):1820-1840. PubMed ID: 32351296
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta-analysis.
Zhu F; Zhang X; Li P; Zhu Y
Helicobacter; 2023 Dec; 28(6):e13013. PubMed ID: 37602719
[TBL] [Abstract][Full Text] [Related]
11. [Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication of
Yoon K; Kim N
Korean J Gastroenterol; 2018 Sep; 72(3):104-115. PubMed ID: 30270592
[TBL] [Abstract][Full Text] [Related]
12. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
13. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
[TBL] [Abstract][Full Text] [Related]
14. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
15. Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia: a 3-year follow-up study.
Lu B; Chen MT; Fan YH; Liu Y; Meng LN
World J Gastroenterol; 2005 Nov; 11(41):6518-20. PubMed ID: 16425426
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer.
Farinati F; Valiante F; Germanà B; Della Libera G; Baffa R; Rugge M; Plebani M; Vianello F; Di Mario F; Naccarato R
Eur J Cancer Prev; 1993 Jul; 2(4):321-6. PubMed ID: 8358284
[TBL] [Abstract][Full Text] [Related]
17. Review article: exploring the link between Helicobacter pylori and gastric cancer.
Kuipers EJ
Aliment Pharmacol Ther; 1999 Mar; 13 Suppl 1():3-11. PubMed ID: 10209681
[TBL] [Abstract][Full Text] [Related]
18. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis.
Khan MY; Aslam A; Mihali AB; Shabbir Rawala M; Dirweesh A; Khan S; Adler DG; Siddiqui A
Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):686-694. PubMed ID: 32355093
[TBL] [Abstract][Full Text] [Related]
20. Does treatment of Helicobacter pylori infection reduce gastric precancerous lesions?
Mansour-Ghanaei F; Joukar F; Mojtahedi K; Sokhanvar H; Askari K; Shafaeizadeh A
Asian Pac J Cancer Prev; 2015; 16(4):1571-4. PubMed ID: 25743833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
